Background Rewiring of metabolism induced by oncogenicK-Rasin cancer cells involves both glucose and glutamine utilization sustaining enhanced, unrestricted growth. The development of effective anti-cancer treatments targeting metabolism may be facilitated by the identification and rational combinatorial targeting of metabolic pathways. Methods We performed mass spectrometric metabolomics analysis in vitro and in vivo experiments to evaluate the efficacy of drugs and identify metabolic connectivity. Results We show thatK-Ras-mutant lung and colon cancer cells exhibit a distinct metabolic rewiring, the latter being more dependent on respiration. Combined treatment with the glutaminase inhibitor CB-839 and the PI3K/aldolase inhibitor NVP-BKM120 more consistently reduces cell growth of tumor xenografts. Maximal growth inhibition correlates with the disruption of redox homeostasis, involving loss of reduced glutathione regeneration, redox cofactors, and a decreased connectivity among metabolites primarily involved in nucleic acid metabolism. Conclusions Our findings open the way to develop metabolic connectivity profiling as a tool for a selective strategy of combined drug repositioning in precision oncology.

Gaglio., D., Bonanomi, M., Valtorta, S., Bharat, R., Ripamonti, M., Conte, F., et al. (2020). Disruption of redox homeostasis for combinatorial drug efficacy in K-Ras tumors as revealed by metabolic connectivity profiling. CANCER & METABOLISM, 8(1) [10.1186/s40170-020-00227-4].

Disruption of redox homeostasis for combinatorial drug efficacy in K-Ras tumors as revealed by metabolic connectivity profiling

Marcella Bonanomi;Silvia Valtorta;Rohit Bharat;Anna Maria Colangelo;Marco Vanoni;Rosa Maria Moresco;Lilia Alberghina
2020

Abstract

Background Rewiring of metabolism induced by oncogenicK-Rasin cancer cells involves both glucose and glutamine utilization sustaining enhanced, unrestricted growth. The development of effective anti-cancer treatments targeting metabolism may be facilitated by the identification and rational combinatorial targeting of metabolic pathways. Methods We performed mass spectrometric metabolomics analysis in vitro and in vivo experiments to evaluate the efficacy of drugs and identify metabolic connectivity. Results We show thatK-Ras-mutant lung and colon cancer cells exhibit a distinct metabolic rewiring, the latter being more dependent on respiration. Combined treatment with the glutaminase inhibitor CB-839 and the PI3K/aldolase inhibitor NVP-BKM120 more consistently reduces cell growth of tumor xenografts. Maximal growth inhibition correlates with the disruption of redox homeostasis, involving loss of reduced glutathione regeneration, redox cofactors, and a decreased connectivity among metabolites primarily involved in nucleic acid metabolism. Conclusions Our findings open the way to develop metabolic connectivity profiling as a tool for a selective strategy of combined drug repositioning in precision oncology.
Articolo in rivista - Articolo scientifico
Metabolic rewiring, metabolic cancer therapy, metabolic signature, glycolysis, glutamine, combinatorial drugs treatment, precision oncology, metabolic connectivity.
English
29-set-2020
2020
8
1
22
open
Gaglio., D., Bonanomi, M., Valtorta, S., Bharat, R., Ripamonti, M., Conte, F., et al. (2020). Disruption of redox homeostasis for combinatorial drug efficacy in K-Ras tumors as revealed by metabolic connectivity profiling. CANCER & METABOLISM, 8(1) [10.1186/s40170-020-00227-4].
File in questo prodotto:
File Dimensione Formato  
10281-284343_VoR.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 5.34 MB
Formato Adobe PDF
5.34 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/284343
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 10
Social impact